Stanozolol 25 mg is an oral stanozolol tablet manufactured by Generic Asia and dosed at 25 mg per tablet in a 50-tablet pack.
Stanozolol 25 mg contains stanozolol, an oral anabolic-androgenic steroid (AAS) derived from dihydrotestosterone. Stanozolol was formerly FDA-approved in the United States for the treatment of hereditary angioedema, a condition causing episodes of swelling of the face, extremities, genitals, bowel wall, and throat . The brand-name oral tablet product is now listed as discontinued, and stanozolol is no longer marketed for human use in the USA . In non-medical bodybuilding settings, stanozolol is commonly referenced for its ability to promote lean, dry muscle gains and enhance vascularity, particularly during cutting phases.
Stanozolol works by binding to androgen receptors in muscle tissue, stimulating protein synthesis and nitrogen retention . Unlike testosterone, stanozolol is not aromatized to estrogen, meaning it does not convert to estrogen and is less likely to cause estrogenic side effects such as gynecomastia or water retention. As a 17-alpha-alkylated compound, stanozolol is orally bioavailable but also hepatotoxic, placing stress on the liver .
While stanozolol's medical applications are limited and its human product is discontinued, its use for physique or performance enhancement falls outside approved medical indications. The FDA labeling for anabolic steroids states they have not been shown to enhance athletic ability . Non-medical use should be considered in the context of significant adverse effects, including liver toxicity, lipid profile changes, and androgenic effects.
Stanozolol is an oral anabolic-androgenic steroid that was first approved in the United States in the early 1960s. Its pharmacological properties and historical context distinguish it from other oral AAS, particularly its non-aromatizing nature and its association with hepatotoxicity.
Stanozolol is a synthetic derivative of dihydrotestosterone with a pyrazole ring modification that makes it orally active and resistant to metabolism by 3-hydroxysteroid dehydrogenase . This structural modification is what allows the compound to survive the digestive process and enter the bloodstream, but it also contributes to its hepatotoxic potential as a 17-alpha-alkylated compound .
Stanozolol has been characterized as having strong anabolic activity with relatively low androgenic activity compared to testosterone, though it is not free of androgenic effects. The FDA labeling for stanozolol notes that anabolic steroids may cause virilization in women and children, and that some virilizing changes may be irreversible .
Stanozolol was historically used to treat hereditary angioedema by increasing serum concentration of C1 esterase inhibitor, thereby reducing the frequency and severity of swelling attacks . It has also been used off-label for osteoporosis management in some case reports .
Stanozolol's combination of oral bioavailability and lack of aromatization distinguishes it from testosterone and many other AAS. It does not convert to estrogen, making it less likely to cause water retention or gynecomastia, but its 17-alpha-alkylated structure carries significant hepatotoxic potential.
Generic Asia offers several products that are commonly referenced in bodybuilding contexts. Stanozolol is an oral AAS with a distinct profile compared to other compounds.
For those seeking a non-aromatizing oral compound often referenced for lean muscle preservation, Oxandrolone 25 mg contains oxandrolone, which is also non-aromatizing but generally considered milder on the liver. Dianabol 25 mg is a methandienone product that aromatizes to estrogen and is commonly referenced for bulking cycles. Anadrol 25 mg is a highly anabolic oral compound often referenced for rapid mass gain. Each compound has distinct properties and applications.
Published laboratory reports for Stanozolol 25 mg are shown below with the test date, measured content and percentage of the product's 25 mg label claim.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every tablet or production batch.
The information below is provided for educational reference only. Stanozolol is a prescription medication with discontinued human marketing in the USA; medical use, where applicable, requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In historical medical settings, stanozolol dosing for hereditary angioedema was 2 mg orally three times daily initially, with maintenance doses decreased to 2 mg per day . In non-medical bodybuilding contexts, stanozolol is commonly referenced at dosages of 25–50 mg per day for oral use, with cycle durations typically limited to 4–6 weeks due to hepatotoxicity concerns.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Historical medical (angioedema) | 2–6 mg daily | Divided doses |
| Non-medical (bodybuilding, oral) | 25–50 mg daily | Once or divided |
| Non-medical (experienced users) | 50–100 mg daily | Once or divided |
In non-medical bodybuilding contexts, stanozolol is commonly referenced during cutting phases to support lean muscle preservation and enhance vascularity. It may be discussed alongside compounds such as Oxandrolone 25 mg, another non-aromatizing oral AAS often referenced for cutting, though stacking multiple 17-alpha-alkylated compounds increases hepatic stress.
Stanozolol is not typically used as a base compound for bulking cycles, where more aromatizing compounds such as Dianabol 25 mg are more commonly referenced. Cycle structure and support protocols should be considered in the context of individual experience, health status and bloodwork where possible.
Stanozolol is a 17-alpha-alkylated compound, and medical literature notes that prolonged high-dosage use has been associated with peliosis hepatis, hepatic neoplasms, and hepatocellular carcinoma . Liver function tests are recommended during stanozolol therapy .
Stanozolol can also affect lipid profiles, decreasing HDL cholesterol and potentially increasing LDL . Cardiovascular monitoring is therefore relevant. Androgenic side effects such as acne, hair loss, and virilization in women may occur, and some virilizing changes can be irreversible .
Stanozolol suppresses endogenous testosterone production, and post-cycle therapy is commonly referenced in non-medical bodybuilding contexts to support hormonal recovery. SERM agents such as tamoxifen or clomiphene are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Stanozolol is a controlled anabolic-androgenic steroid. Its human product is discontinued in the USA, and non-medical use carries significant health risks. Medical use, where still applicable, requires appropriate diagnosis, clinical supervision and ongoing monitoring.
Stanozolol carries significant hepatotoxic potential as a 17-alpha-alkylated anabolic steroid. Prolonged high-dosage use has been associated with peliosis hepatis (blood-filled cysts in the liver), hepatic neoplasms, and hepatocellular carcinoma . Cholestatic jaundice and elevated liver enzymes (GOT, GPT) have been reported, and periodic liver function testing is recommended during therapy .
Stanozolol can cause blood lipid changes known to increase cardiovascular risk, including decreased HDL and sometimes increased LDL cholesterol . Anabolic steroids may also increase sensitivity to anticoagulants, potentially requiring dose adjustment of blood thinners .
Stanozolol's approved medical indication was limited to hereditary angioedema, and the human oral product is now discontinued in the USA . The FDA labeling states that anabolic steroids have not been shown to enhance athletic ability . Use for bodybuilding or performance enhancement falls outside approved medical indications and is associated with significant health risks.
Commonly reported side effects of stanozolol include acne, changes in libido, and headaches . In women, virilization effects such as deepening of the voice, hirsutism, acne, and clitoral enlargement may occur, and some changes may be irreversible . In men, stanozolol can suppress endogenous testosterone production and cause gynecomastia, acne, and testicular dysfunction .
Serious adverse effects include liver toxicity, blood lipid changes, and fluid retention . Stanozolol is contraindicated in pregnancy and can cause birth defects . It should be used with caution in patients with diabetes, heart disease, kidney disease, or liver impairment .
Stanozolol is contraindicated in patients with prostate cancer, breast cancer in males, hypercalcemia, or porphyria . It should be used with caution in patients with pre-existing cardiac, renal, or hepatic disease, hypertension, epilepsy, migraines, or diabetes .
Women who are pregnant or breastfeeding should not use stanozolol. Individuals planning to have children should discuss potential fertility effects with a healthcare professional .
Medical stanozolol therapy typically involves periodic liver function tests due to hepatotoxicity potential . Lipid profiles and hemoglobin/hematocrit may also be monitored. Blood glucose should be monitored in diabetic patients .
Laboratory testing of the product itself, such as the published potency report shown in the Lab Reports tab, is separate from clinical monitoring of the person using stanozolol.
Store in a closed container at room temperature, away from heat, moisture, and direct light . Keep all medications out of the reach of children. Follow the storage instructions provided with the product packaging.
Stanozolol 25 mg is supplied through the official Generic Asia distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Generic Asia distribution chain.
To verify your Stanozolol 25 mg product, use the security code on the product packaging and cross-check it on the Generic Asia official site. Official Generic Asia presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve product integrity and ensure the tablets remain suitable for their intended use throughout their shelf life.
Store stanozolol tablets in a closed container at room temperature, away from heat, moisture, and direct light . Keep the tablets in their original packaging until use to protect them from contamination.
Do not store in areas subject to temperature extremes, such as bathrooms or near kitchen appliances. Keep out of reach of children and pets.
Answers to common questions about Stanozolol 25 mg, stanozolol, its mechanisms, dosage considerations and safety information.
Stanozolol 25 mg contains stanozolol, an oral anabolic-androgenic steroid. Historically, it was approved for the treatment of hereditary angioedema, but the human oral product is now discontinued in the USA . In non-medical bodybuilding settings, it is commonly referenced for lean muscle preservation and vascularity during cutting phases, though such use falls outside approved medical indications.
In historical medical settings, stanozolol was dosed at 2 mg three times daily initially, with maintenance doses of 2 mg per day . In non-medical bodybuilding contexts, it is commonly referenced at 25–50 mg per day, often taken as a single dose or divided, for cycle durations of 4–6 weeks.
Yes, stanozolol suppresses endogenous testosterone production, and post-cycle therapy is commonly referenced in non-medical contexts to support hormonal recovery. SERM agents such as tamoxifen or clomiphene are commonly referenced for this purpose. PCT protocols vary based on cycle length and individual factors.
Stanozolol binds to androgen receptors in muscle tissue, stimulating protein synthesis and nitrogen retention . It is a derivative of dihydrotestosterone with a pyrazole ring modification that makes it orally active and non-aromatizing . It does not convert to estrogen, distinguishing it from testosterone and many other AAS.
In veterinary medicine, stanozolol is noted to take effect within 1 to 2 hours, though effects may not be visibly obvious and laboratory tests may be needed to evaluate effectiveness . In non-medical bodybuilding contexts, users commonly report noticeable changes in muscle hardness and vascularity within the first one to two weeks of a cycle. Individual response varies based on dosage, training, and nutrition.
There is no single oral steroid that is universally best for cutting. Stanozolol is known for producing hard, dry gains and is non-aromatizing, but it also carries significant hepatotoxic potential . Other compounds such as Oxandrolone 25 mg offer a different risk-benefit profile. The appropriate choice depends on individual goals, health status, and risk tolerance.
Stanozolol and Oxandrolone are both oral AAS with non-aromatizing profiles, often referenced in cutting contexts. Stanozolol is known for producing harder, drier gains but is also associated with joint discomfort in some users. Oxandrolone 25 mg contains oxandrolone, which is generally considered milder on the liver but may produce less dramatic visual changes. Both are 17-alpha-alkylated and carry hepatotoxic potential.
Stanozolol and Dianabol (methandienone) are both oral AAS, but they serve different purposes in non-medical contexts. Stanozolol is a non-aromatizing compound commonly referenced for cutting and lean gains. Dianabol 25 mg is an aromatizing compound often referenced for bulking cycles and more rapid mass gain, though with greater estrogenic side effect potential. Both are 17-alpha-alkylated and carry hepatotoxic potential.
In historical medical settings, stanozolol doses were much lower, typically 2–6 mg daily . In non-medical bodybuilding contexts, 25 mg per day represents a moderate starting dose, with ranges commonly referenced at 25–50 mg daily. However, any use outside medical supervision carries significant risks, and individual response varies.
Stanozolol 25 mg is labeled at 25 mg of stanozolol per tablet. It is supplied as 50 oral tablets per package, giving 1,250 mg of total labeled content.
Yes. A published laboratory report dated March 9, 2023 measured Stanozolol 25 mg at 24.57 mg per tablet, equivalent to 98.28% of its 25 mg label claim. The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report.
Stanozolol is sometimes referenced in non-medical contexts by women, but it carries significant virilization risk. Medical labeling advises that women be observed for signs of virilization, including deepening of the voice, hirsutism, acne, and clitoral enlargement, and that some changes may be irreversible even after discontinuation . Any consideration of stanozolol use by women should involve careful evaluation of risks.